| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.5M | — | +2.1% |
| Cost of Revenue | $1.2M | — | +37.2% |
| R&D Expense | $6.7M | — | +117.7% |
| SG&A Expense | $7.2M | — | +45.7% |
| Operating Income | -$9.4M | — | -511.6% |
| Pre-tax Income | -$9.2M | — | -299.3% |
| Income Tax | $621K | — | -31.1% |
| Net Income | -$9.9M | — | -364.0% |
| EPS (Basic) | -$0.10 | — | -433.3% |
| EPS (Diluted) | -$0.10 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.5M | +1.2% | +149.3% |
| Short-term Investments | $12.3M | -19.9% | -17.1% |
| Accounts Receivable | $22.8M | -26.8% | +13.0% |
| Inventory | $11.4M | +11.6% | +44.1% |
| Current Assets | $91.7M | -10.4% | +34.0% |
| Total Assets | $162.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.2M | — | +2565.1% |
| Capital Expenditures | $178K | — | +45.9% |
| Investing Cash Flow | -$3.1M | — | -255.3% |
| Financing Cash Flow | $21K | — | -98.4% |
| Free Cash Flow | $3.0M | — | +1296.0% |
| +24.8% |
| Current Liabilities | $19.8M | +8.2% | +4.2% |
| Total Liabilities | $25.0M | +4.9% | -1.8% |
| Stockholders' Equity | $101.3M | -4.5% | +48.7% |